Document:

Exhibit 4.54

 

ANNEX I

TO

BRIDGE LOAN AGREEMENT

 

FORM OF NOTE

 

THIS NOTE AND THE SECURITIES UNDERLYING
THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES
LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE COMPANY
OF AN OPINION OF COUNSEL IN THE FORM, SUBSTANCE AND SCOPE REASONABLY SATISFACTORY TO THE COMPANY THAT THIS NOTE AND THE SECURITIES
UNDERLYING THIS NOTE MAY BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF, UNDER AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND
SUCH STATE SECURITIES LAWS.

 

No. _______1

Original Issue Date: [ ], 2019

Face Amount: $[ ]

Purchase
Price: $[ ]2

 

EHAVE, INC.

 

15% ORIGINAL ISSUE DISCOUNT PROMISSORY NOTE

 

DUE [            ,20193]

 

THIS NOTE is one of
a duly authorized issue of promissory notes of up to $[500,000] original principal amount in the aggregate of EHAVE, INC., a corporation
organized and existing under the laws of the province of Ontario (the “Company”), designated as its 15%
Original Issue Discount Promissory Notes.

 

FOR VALUE RECEIVED,
the Company promises to pay to _____________________, the registered holder hereof (the “Holder”), the
principal sum of $________________4 (as such amount may be reduced pursuant to any conversion or otherwise in accordance
with the terms hereof, the “Principal”) and to pay interest on the outstanding Principal from time to
time in arrears at the rate of 15% per annum, accruing from the Issue Date (as defined below) pursuant to the terms hereof.

 

 

1 Insert unique Note number for each issuance.

2 90% of Principal

3 180 days from the issuance date

4 See fn 2.

 

    	 	 	 

     

    

 

This Note was originally
issued on [ ], 20195 (the “Issue Date”).

 

This Note is being
issued pursuant to the terms of the Bridge Loan Agreement, dated as of [ ], 2019 (the “Bridge Loan Agreement”),
to which the Company and the Holder (or the Holder’s predecessor in interest) are parties. Capitalized terms not otherwise
defined herein shall have the meanings ascribed to them in the Bridge Loan Agreement.

 

This Note is subject
to the following additional provisions:

 

1.          The
Note will initially be issued in denominations determined by the Company, but are exchangeable for an equal aggregate Principal
amount of Note of different denominations, as requested by the Holder surrendering the same. No service charge will be made for
such registration or transfer or exchange.

 

2.          Interest
at the rate of 15% per cent per annum will accrue from the Issue Date until the Maturity Date (as defined below), and shall be
computed on the basis of a 365-day year and the actual number of days elapsed.

 

3.          Unless
earlier converted pursuant to Section 6, all unpaid Principal of this Note, together with then unpaid accrued interest, if any,
and any other amounts due hereunder, shall be due and payable on [__, 2019] (the “Maturity Date”).6

 

4.          The
Company shall be entitled to withhold from all payments of principal of, and, if applicable, interest on, this Note any amounts
required to be withheld under the applicable provisions of the United States income tax laws or other applicable laws at the time
of such payments, and the Holder shall execute and deliver all required documentation in connection therewith.

 

5.          This
Note has been issued subject to investment representations of the original purchaser hereof set forth in the Bridge Loan Agreement
and may be transferred or exchanged only in compliance with the 1933 Act, other applicable state and foreign securities laws and
the terms of the Bridge Loan Agreement. In the event of any proposed transfer of this Note, the Company may require, prior to issuance
of a new Note in the name of such other person, that it receive reasonable transfer documentation that is sufficient to evidence
that such proposed transfer complies with the 1933 Act and other applicable state and foreign securities laws and the terms of
the Bridge Loan Agreement. Prior to due presentment for transfer of this Note, the Company and any agent of the Company may treat
the person in whose name this Note is duly registered on the Company’s Note Register as the owner hereof for the purpose
of receiving payment as herein provided and for all other purposes, whether or not this Note be overdue, and neither the Company
nor any such agent shall be affected by notice to the contrary.

 

 

5 Insert the Closing Date.

6 180 days from the issuance date

 

    	 	- 2 -	 

     

    

 

6.           Conversion.

 

(a)          Upon
the closing of a Subsequent Equity Financing, and provided that this Note remains outstanding on such day, the outstanding Principal
balance, unpaid accrued interest thereon and all other amounts outstanding under this Note shall convert automatically, without
any further consent or action of the Holder, into the equity securities sold in such Subsequent Equity Financing (the “Conversion
Securities”) at a price per equity security equal to the lesser of (i) 75% (i.e., a 25% discount) of the price per
equity security at which such securities are sold in such Subsequent Equity Financing, and (ii) $ 0.000909776 per share (the “Conversion
Price”). The Holder covenants and agrees that it shall, in connection with the conversion of this Note pursuant to
this Section 6(a), execute and deliver to the Company each agreement and other instrument executed by the investors in the Subsequent
Equity Financing. The Company shall not be required to issue the Conversion Securities to the Holder unless and until the Holder
executes such agreements and instruments pursuant to the immediately preceding sentence. For purposes hereof, “Subsequent
Equity Financing” means the consummation by the Company of a financing transaction with aggregate gross proceeds
to the Company of not less than $2,000,000, excluding any and all Notes which are converted into such financing transaction, pursuant
to which the Company sells Common Shares, Common Share Equivalents or other capital stock of the Company for the purposes of raising
capital, other than the at a Closing pursuant to the Bridge Loan Agreement.

 

(b)          If
an Event of Default shall have occurred and is continuing, and in each and every such case, unless such Event of Default shall
have been cured or waived in writing by a Majority in Interest of the Holders, the Conversion Price shall be 90% (i.e., a 10% discount)
of the VWAP on the date of the applicable notice of conversion. “VWAP” means, for any date, the price
determined by the first of the following clauses that applies: (a) if the Common Shares are then listed or quoted on any of the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange
(or any successors to any of the foregoing ) (the “Trading Market”), the daily volume weighted average
price of the Common Shares for such date (or the nearest preceding date) on the Trading Market on which the Common Shares are then
listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York
City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date
(or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading
on OTCQB or OTCQX and if prices for the Common Shares are then reported in the “Pink Sheets” published by OTC Markets
Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Shares so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an
independent appraiser selected in good faith by the Majority in Interest of the Holders and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.

 

7.          No
fractional shares of Conversion Securities shall be issued upon conversion of this Note. In lieu of the Company issuing any fractional
shares of Conversion Securities to the Holder upon the conversion of this Note, the Company shall round down the number of Conversion
Securities to be issued hereunder to the nearest whole number of Conversion Securities. Upon conversion of this Note pursuant to
Section 6, the Company shall be forever released from all its obligations and liabilities under this Note and this Note shall be
deemed of no further force or effect, whether or not the original of this Note has been delivered to the Company for cancellation.

 

    	 	- 3 -	 

     

    

 

8.           Subject
to Section 7 hereto, any payment made to the Holder shall be applied in the following order of priority: (a) first, to any amounts
due to the Holder hereunder or under any of the Transaction Agreements other than Principal and accrued interest, (b) second, to
accrued and unpaid interest and (b) then, to Principal of this Note.

 

9.           The
Company may, in its sole discretion, prepay all or any portion of this Note at any time prior to the Maturity Date or the conversion
of this Note pursuant to Section 6.

 

10.          Subject
to Section 6 and Section 7 hereto, all payments contemplated hereby are to be made “in cash” and shall be made in immediately
available good funds of United States of America currency by wire transfer to an account designated in writing by the Holder to
the Company (which account may be changed by notice similarly given) or certified check payable to the order of the Holder and
sent by first class mail to the address of the Holder set forth in the Company’s Note Register. For purposes of this Note,
the phrase “date of payment” means the date funds are received in the account designated by the notice which is then
currently effective or the date that a certified check is deposited with the United States Postal Service, as applicable.

 

11.          Subject
to the terms of the Bridge Loan Agreement and the terms of this Note, no provision of this Note shall alter or impair the obligation
of the Company, which is absolute and unconditional, to pay the Principal of, and, if applicable, interest on, this Note at the
time, place, and rate, and in the coin or currency or other consideration, as herein prescribed. This Note is a direct obligation
of the Company.

 

12.          No
recourse shall be had for the payment of the Principal of, or the interest on, this Note, or for any claim based hereon, or otherwise
in respect hereof, against any incorporator, shareholder, officer or director, as such, past, present or future, of the Company
or any successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment
or penalty or otherwise, all such liability being, by the acceptance hereof and as part of the consideration for the issue hereof,
expressly waived and released.

 

13.          The
Holder, by acceptance hereof, agrees that this Note is being acquired for investment and the Holder will not offer, sell or otherwise
dispose of this Note or the Conversion Securities acquired upon conversion hereof, except under circumstances which will not result
in a violation of the 1933 Act or any applicable state securities “blue sky” or foreign laws or similar laws relating
to the sale of securities.

 

14.          Any
notice required or permitted hereunder shall be given in the manner provided in the Section headed “NOTICES” in the
Bridge Loan Agreement, the terms of which are incorporated herein by reference.

 

15.          This
Note shall be governed by and interpreted in accordance with the laws of the State of New York for contracts to be wholly performed
in such state and without giving effect to the principles thereof regarding the conflict of laws. Each of the parties consents
to the exclusive jurisdiction of the federal courts whose districts encompass any part of the County of New York or the state courts
of the State of New York sitting in the County of New York in connection with any dispute arising under this Note and hereby waives,
to the maximum extent permitted by law, any objection, including any objection based on forum non conveniens, to the bringing of
any such proceeding in such jurisdictions. To the extent determined by such court, the Company shall reimburse the Holder for any
reasonable legal fees and disbursements incurred by the Holder in enforcement of or protection of any of its rights under this
Note.

 

    	 	- 4 -	 

     

    

 

16.          The
Company and the Holder hereby waive a trial by jury in any action, proceeding or counterclaim brought by either of such parties
against the other in respect of any matter arising out of or in connection with this Note.

 

17.          Any
one or more of the following shall constitute an “Event of Default”:

 

(a)          Any
of the representations or warranties made by the Company herein, in the Bridge Loan Agreement or any of the other Transaction Agreements
shall be false or misleading in any material respect at the time made; or

 

(b)          The
Company shall fail to perform or observe, in any material respect, any covenant, term, provision, condition, agreement or obligation
of any Note in this series and, if such failure is subject to cure, such failure shall continue uncured for a period of forty-five
(45) days after the Company’s receipt of written notice thereof from the Holder (but if such failure is not subject to cure,
then immediately on the Company’s receipt of such written notice); or

 

(c)          The
Company shall fail to perform or observe, in any material respect, any covenant, term, provision, condition, agreement or obligation
of the Company under any of the Transaction Agreements, and, if such failure is subject to cure, such failure shall continue uncured
for a period of forty-five (45) days after the Company’s receipt of written notice thereof from the Holder (but if such failure
is not subject to cure, then immediately on the Company’s receipt of such written notice); or

 

(d)          A
trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without
its consent and shall not be discharged within ninety (90) days after such appointment; or

 

(e)          Any
governmental agency or any court of competent jurisdiction at the instance of any governmental agency shall assume custody or control
of the whole or any substantial portion of the properties or assets of the Company and shall not be dismissed within ninety (90)
days thereafter; or

 

(f)          Any
final money judgment, writ or warrant of attachment, or similar process in excess of Five Hundred Thousand ($500,000) Dollars in
the aggregate shall be entered or filed against the Company or any of its properties or other assets and shall remain unpaid, unvacated,
unbonded or unstayed for a period of ninety (90) days or in any event later than five (5) days prior to the date of any proposed
sale thereunder; or

 

(g)          Bankruptcy,
reorganization, insolvency or liquidation proceedings or other proceedings for relief under any bankruptcy law or any law for the
relief of debtors shall be instituted by or against the Company and, if instituted against the Company, shall not be dismissed
within ninety (90) days after such institution or the Company shall by any action or answer approve of, consent to, or acquiesce
in any such proceedings or admit the material allegations of, or default in answering a petition filed in any such proceeding.

 

    	 	- 5 -	 

     

    

 

If an Event of Default
shall have occurred and is continuing, then, or at any time thereafter, and in each and every such case, unless such Event of Default
shall have been cured or waived in writing by a Majority in Interest of the Holders (which waiver shall not be deemed to be a waiver
of any subsequent default), at the option of a Majority in Interest of Holders and in the Majority in Interest of Holders’
sole discretion, and upon the written notice by a Majority in Interest of Holders, this Note shall immediately become due and payable,
without presentment, demand, protest or notice of any kind, all of which are hereby expressly waived, anything herein or in any
note or other instruments contained to the contrary notwithstanding, and the Majority in Interest of Holders may immediately enforce
any and all of the Holder’s rights and remedies provided herein or any other rights or remedies afforded by law, including,
but not necessarily limited to, the equitable remedy of specific performance and injunctive relief.

 

18.          Any
provision of this Note may be amended, waived or modified upon the written consent of the Company and a Majority in Interest of
Holders; provided, however, that no such amendment, waiver or consent shall: (i) reduce the Principal amount of this
Note without Holder’s written consent, or (ii) reduce the rate of interest of this Note without Holder’s written consent.

 

19.          In
the event for any reason, any payment by or act of the Company or the Holder shall result in payment of interest which would exceed
the limit authorized by or be in violation of the law of the jurisdiction applicable to this Note, then ipso facto the obligation
of the Company to pay interest or perform such act or requirement shall be reduced to the limit authorized under such law, so that
in no event shall the Company be obligated to pay any such interest, perform any such act or be bound by any requirement which
would result in the payment of interest in excess of the limit so authorized. In the event any payment by or act of the Company
shall result in the extraction of a rate of interest in excess of a sum which is lawfully collectible as interest, then such amount
(to the extent of such excess not returned to the Company) shall, without further agreement or notice between or by the Company
or the Holder, be deemed applied to the payment of Principal, if any, hereunder immediately upon receipt of such excess funds by
the Holder, with the same force and effect as though the Company had specifically designated such sums to be so applied to Principal
and the Holder had agreed to accept such sums as an interest-free prepayment of this Note. If any part of such excess remains after
the Principal has been paid in full, whether by the provisions of the preceding sentences of this Section or otherwise, such excess
shall be deemed to be an interest-free loan from the Company to the Holder, which loan shall be payable immediately upon demand
by the Company. The provisions of this Section shall control every other provision of this Note.

 

[Signature Page Follows]

 

    	 	- 6 -	 

     

    

 

IN WITNESS WHEREOF,
the Company has caused this instrument to be duly executed by an officer thereunto duly authorized.

 

	Dated: [__], 2019	 	 
	 	 	 
	 	EHAVE, INC.
	 	 	 
	 	By:	 
	 	 	 
	 	 
	 	(Print Name)
	 	 
	 	(Title)

 

15% Senior Convertible Promissory
NoteExhibit 4.55

 

AGREEMENT

 

 

 

THIS AGREEMENT
(the “Agreement”) is made and entered into as of February 27, 2019, by and between Ehave, Inc. (the “Company”),
and Bezaelel Partners, LLC (the “Grantee”), a shareholder of the Company.

 

WITNESSETH:

 

WHEREAS, the
Grantee owns 3,798,781common shares (“Old Shares”) issued on July 2, 2018, which the Grantee was unable
to deposit with Alpine Securities Corporation due to lack of supporting documentation.

 

WHEREAS, the
Company is entering into agreements with holders of the Company’s notes and warrants, pursuant to which certain outstanding
notes and warrants shall be converted into common shares of the Company (the “Recapitalization”);

 

WHEREAS, the
Grantee has introduced the Company to potential partners for one or more strategic transactions, including mergers or acquisitions
(the “Services”).

 

WHEREAS, upon
completion of the Recapitalization, the Company desires to issue 47,564,189 common shares of the Company (the “Shares”)
(i) for the Grantee’s Services and (ii) in exchange for the Old Shares, upon and subject to the terms and conditions set
forth herein.

 

NOW, THEREFORE,
in consideration of the promises and the mutual covenants and agreements of the parties herein contained, the Company and the Grantee
hereby agree as follows:

 

1.          Recitals.
The foregoing recitals are hereby incorporated herein by reference and acknowledged as true and correct by the parties hereto.

 

2.          Issuance
of Shares.

 

2.1           The
Company hereby agrees to issue to the Grantee, the Shares, upon completion of the Recapitalization and deliver to Grantee a certificate
representing the Shares in the name of the Grantee (the “Certificate”).

 

2.2           The
Grantee hereby acknowledges that the Shares are being issued to the Grantee (i) for the Grantee’s
Services and (ii) in exchange for the Old Shares. The Grantee shall surrender its certificate for the Old Shares, duly endorsed
(or a notice to the effect that the original share certificate has been lost, stolen or destroyed and an agreement acceptable to
the Company whereby the holder agrees to indemnify the Company from any loss incurred by it in connection with the share certificate),
at the office of the Company. The Company shall, as soon as practicable thereafter, issue and deliver to the Grantee a Certificate
representing the Shares pursuant to this Agreement (bearing such legends as are required by applicable state and federal securities
laws in the opinion of counsel to the Company).

 

3.          Representations
and Warranties of the Company. The Company hereby represents and warrants to the Grantee as follows:

 

    	 	1	 

     

    

 

3.1           Authorization.
The Company has all requisite power, legal capacity and authority to enter into this Agreement and to assume and perform its obligations
hereunder. This Agreement, when duly executed and delivered by the Company, will constitute a legal, valid and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except as the enforceability thereof may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors’ rights generally
or by the principles governing the availability of equitable remedies.

 

3.2           Approvals
and Consents. No action, approval, consent or authorization, including but not limited to, any action, approval, consent
or authorization by any governmental or quasi-governmental agency, commission, board, bureau or instrumentality is necessary or
required as to the Company in order to constitute this Agreement as a valid, binding and enforceable obligation of the Company
in accordance with its terms.

 

4.          Representations
and Warranties of the Grantee. The Grantee hereby represents and warrants to the Company as follows:

 

4.1           Authorization.
The Grantee has all requisite power, legal capacity and authority to enter into this Agreement and to assume and perform its obligations
hereunder. This Agreement, when duly executed and delivered by such Grantee, will constitute a legal, valid and binding obligation
of such Grantee, enforceable against the Grantee in accordance with its terms, except as the enforceability thereof may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors’ rights generally
or by the principles governing the availability of equitable remedies.

 

4.2           Approvals
and Consents. No action, approval, consent or authorization, including, but not limited to, any action, approval, consent
or authorization by any governmental or quasi-governmental agency, commission, board, bureau or instrumentality is necessary or
required as to the Grantee in order to constitute this Agreement as a valid, binding and enforceable obligation of the Grantee
in accordance with its terms.

 

4.3           Accredited
Investor. The Grantee is an “accredited investor,” as such term is defined in Rule 501 of Regulation D promulgated
under the Securities Act of 1933, as amended (the “Securities Act”), and such Grantee is able to bear
the economic risk of an investment in the Shares.

 

4.4           Restricted
Stock/Control Securities. The Shares are being acquired for the Grantee’s own account, for investment and not with
a view to the distribution thereof. The Grantee understands that such Shares have not been registered under the Securities Act
and may not be resold unless a subsequent disposition thereof is registered under the Securities Act or is exempt from registration
under the Securities Act.

 

4.5           No
General Solicitation. The Grantee is not receiving the Shares as a result of any advertisement, article, notice or other
communication regarding the Shares published in any newspaper, magazine or similar media or broadcast over television or radio
or presented at any seminar or any other general solicitation or general advertisement.

 

    	 	2	 

     

    

 

4.6           Legend.
The Grantee understands and agrees that the Certificates shall bear substantially the following legend until (a) such Shares shall
have been registered under the Securities Act and effectively disposed of in accordance with a registration statement that has
been declared effective or (b) in the opinion of counsel for the Company, such Shares may be sold without registration under the
Securities Act, as well as any applicable “blue sky” or state securities laws:

 

“THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR ANY APPLICABLE STATE SECURITIES LAWS. SUCH SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT PURPOSES AND MAY NOT BE OFFERED FOR
SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FILED
BY THE ISSUER WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION COVERING SUCH SECURITIES UNDER THE SECURITIES ACT OR AN OPINION
OF COUNSEL SATISFACTORY TO THE ISSUER THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

5.          General
Provisions.

 

5.1           Entire
Agreement; Amendment and Waiver. Except as set forth herein, no representations or warranties have been made to the Grantee
by the Company, and in receiving the Shares, the Grantee is not relying upon any representations other then those specifically
contained herein. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter
contained herein and supersedes all prior oral or written agreements, if any, between the parties hereto with respect to such subject
matter and, except as otherwise expressly provided herein, is not intended to confer upon any other person any rights or remedies
hereunder. Any amendments hereto or modifications hereof must be made in writing and executed by each of the parties hereto. Any
failure by the Company or the Grantee to enforce any rights hereunder shall not be deemed a waiver of such rights.

 

5.2           Consideration
for the Shares. The Grantee and the Company hereby acknowledge, as evidenced by their signatures hereto, that (a) the consideration
for the Shares is fair, equitable and valid; and (b) the Company’s common shares are subject to market forces which will
result in variances in the value thereof, which variances may be significant.

 

5.3           Governing
Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York without giving
effect to conflict of laws principles.

 

5.4           Binding
Effect; Assignment. This Agreement and the various rights and obligations arising hereunder shall inure to the benefit
of and be binding upon the Company and the Grantee and their respective heirs, successors and assigns. Neither this Agreement nor
any of the rights, interests or obligations hereunder shall be transferred or assigned (by operation of law or otherwise) by any
of the parties hereto without the prior written consent of the other party hereto. Any transfer or assignment of any of the rights,
interests or obligations hereunder in violation of the terms hereof shall be void and of no force or effect.

 

5.5           Survival
of Representations and Warranties. All representations and warranties made by the parties to this Agreement shall survive
the execution and delivery of this Agreement.

 

    	 	3	 

     

    

 

5.6           Counterparts.
This Agreement may be executed in any number of counterparts and each of such counterparts shall be deemed to be an original, and
such counterparts shall together constitute but one and the same instrument and shall bind all parties signing such counterpart.

 

5.7           Additional
Documents. The Company and the Grantee agree to execute any additional documents reasonably required to affect the issuance
of the Shares to the Grantee.

 

[Signature Page
Follows] 

 

    	 	4	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.

 

	 	EHAVE, INC.:
	 	 	 
	 	By:	/s/ Prateek Dwivedi
	 	Name: Prateek Dwivedi
	 	Title: CEO
	 	 	 
	 	Bezalel Partners LLC:
	 	 	 
	 	By:	/s/ David Stefanksy
	 	Name: David Stefanksy
	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}]]